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ABSTRACT
Isopropyl methanesulfonate (IPMS) is the most potent genotoxic compound 
among methanesulfonic acid esters. The genotoxic potential of alkyl sulfonate 
esters is believed to be due to their alkylating ability of the O6 position of guanine. 
Understanding the primary repair pathway activated in response to IPMS-induced 
DNA damage is important to profile the genotoxic potential of IPMS. In the present 
study, both chicken DT40 and human TK6 cell-based DNA damage response (DDR) 
assays revealed that dysfunction of the FANC pathway resulted in higher sensitivity 
to IPMS compared to EMS or MMS. O6-alkyl dG is primarily repaired by methyl 
guanine methyltransferase (MGMT), while isopropyl dG is less likely to be a substrate 
for MGMT. Comparison of the cytotoxic potential of IPMS and its isomer n-propyl 
methanesulfonate (nPMS) revealed that the isopropyl moiety avoids recognition by 
MGMT and leads to higher cytotoxicity. Next, the micronucleus (MN) assay showed 
that FANC deficiency increases the sensitivity of DT40 cells to MN induction by IPMS. 
Pretreatment with O6-benzyl guanine (OBG), an inhibitor of MGMT, increased the 
MN frequency in DT40 cells treated with nPMS, but not IPMS. Lastly, IPMS induced 
more double strand breaks in FANC-deficient cells compared to wild-type cells in a 
time-dependent manner. All together, these results suggest that IPMS-derived O6-
isopropyl dG escapes recognition by MGMT, and the unrepaired DNA damage leads 
to double strand breaks, resulting in MN induction. FANC, therefore, plays a pivotal 
role in preventing MN induction and cell death caused by IPMS.
INTRODUCTION
Isopropyl methane sulfonate (IPMS), an alkyl 
sulfonate, is a potential genotoxic impurity (GTI) that 
can form as a byproduct during the synthesis of sulfonate 
salts when sulfonic acids react with isopropanol, a low 
molecular weight alcohol [1]. IPMS displays genotoxicity 
and carcinogenicity in in vitro and in vivo assays, and it is 
categorized as the most potent mutagen in the Ames and 
in vivo micronucleus assays [2-9]. Despite its hazardous 
profile, there has been little attention on IPMS compared to 
what is known about methyl methanesulfonate (MMS) and 
ethyl methanesulfonate (EMS), which are also potential 
GTIs. These alkyl sulfonates constitute a representative 
class of direct mutagens whose genotoxicity is attributed 
to their alkylating ability at the O6 position of dG [5, 10]. 
The genotoxicity of IPMS has been hypothesized to be 
attributed to the differences in the SN1/SN2 reaction type 
and the Swain Scott constants [11], as compared to MMS 
and EMS [5]. Although IPMS-mediated DNA adduct 
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formation has been previously studied, it is important 
to determine its net biological effect (e.g. cytotoxicity 
and genotoxicity outcome), which is determined by the 
balance between the generation of DNA damage and the 
DNA repair efficiency. Understanding both the damage 
and repair aspects helps to more accurately interpret how 
individual alkylating agents induce genotoxicity. In this 
study, we conducted the DNA damage response (DDR) 
assay using isogenic chicken DT40 cell lines [12-14] to 
understand the repair or tolerant pathway activated in 
response to IPMS. DT40 cells originated from a chicken 
B-lymphocyte line derived from an avian leucosis virus-
induced bursal lymphoma isolated in 1985 [15]. The 
isogenic DT40 cell lines in this study broadly probe 
biological targets, pathways and mechanisms in relation 
to genotoxicity and/or cytotoxicity endpoints for a large 
number of chemicals [16, 17]. The DDR assay, which 
examines cytotoxicity in DNA repair-deficient DT40 
mutants versus the parental DT40 cells, is a rapid and 
simple method to evaluate the genotoxicity of xenobiotics.
Interestingly, small differences in chemical structure 
can drastically change genotoxicity. nPMS is an isomer of 
IPMS with a straight chain in the alkyl side chain structure, 
while IPMS has an isopropyl moiety. Despite the subtle 
change in structure, the genotoxic potential of nPMS is 
significantly weaker than IPMS [2, 4-6, 8, 9]. The difference 
in the activities of these two agents has not been adequately 
explained, but it is believed to be due to a combination of 
the DNA lesion-forming potential and repair or tolerance 
capability. A possible explanation for the different 
efficiencies in the formation of DNA adducts is that IPMS 
is able to form a carbonium ion (SN1) while the reactivity of 
nPMS occurs via a bimolecular nucleophilic displacement 
reaction (SN2). The SN1 reactivity of IPMS indicates that 
it possesses stronger reactivity at the O6 position of dG 
compared to nPMS [18]. As a result, IPMS is believed 
to generate more DNA adducts at the O6 position of dG 
than nPMS. Thus, the SN1/SN2 reaction type and the Swain 
Scott constants are useful values for predicting the potential 
for genotoxicity. However, as previously mentioned, 
genotoxicity is characterized not only by the generation of 
DNA damage but also the effect on DNA damage repair; 
therefore, it is important to characterize the changes in 
repair or tolerance capabilities after IPMS exposure, which 
have not been previously highlighted.
Alkylating agents predominantly form adducts at 
N- and O- atoms, and O-alkylations (e.g., O6-alkyl dG) are 
known to be highly mutagenic and clastogenic. Although 
its proportion is less than 10% of the total number of DNA 
methyl adducts, O-alkylations are stable and persist in the 
absence of the DNA repair protein O6-methylguanine-
DNA methyltransferase (MGMT) [19, 20]. The MGMT 
enzyme repairs these adducts by transferring the alkyl 
group from the oxygen in the guanine to a cysteine residue 
in the catalytic pocket of MGMT [21]. Exposure to IPMS 
results in bulkier adducts, which are slower to repair than 
those induced by ENU [22-24]. Dolan et al. reported that 
MGMT efficiently removes O6-n-propyl guanine, but its 
activity on O6-isopropyl dG is less extensive [25]. It is not 
clear how differences in MGMT repair efficiency impacts 
the cellular response. To address this point, we inhibited 
MGMT activity in cells, exposed these cells to IPMS, 
nPMS or MMS, and examined the cytotoxic or genotoxic 
activity. Because O6-n-propyl dG and O6-methyl dG are 
more effectively repaired by MGMT than O6-isopropyl 
dG, MGMT depletion would be expected to generate 
different responses to each chemical. In this study, cells 
were pre-incubated with O6-benzylguanine (OBG), a 
MGMT inhibitor, and the LC50 and MN induction in DT40 
cells treated with IPMS, nPMS or MMS were measured as 
indices of cytotoxicity and genotoxicity.
Unrepaired O6-alkyl dG forms mispairings with 
deoxythymidine and is recognized by mismatch repair 
(MMR); however, MMR cannot repair O6-methylG/T 
mispairs, which eventually lead to double-strand breaks 
(DSBs). Because O6-isopropyl dG is poorly recognized by 
MGMT, it is highly likely to form mispairings and form DSBs. 
It has been reported that DSB repair pathways are activated 
by methylating agents [26]. Taking this into consideration, 
we measured γ-H2AX as an indicator for formation of DSBs. 
Wild-type and sensitive mutant cells were exposed to IPMS, 
and the population of γ-H2AX positive cells was measured 
to investigate whether the DSBs induced by IPMS causes the 
unique response found in the DDR assay.
RESULTS
Greater cytotoxicity of IPMS in FANC-deficient 
DT40 cells compared to MMS or EMS
To determine the repair or tolerance mechanism 
of IPMS-induce DNA damage, twenty-eight isogenic 
mutant cells were exposed to IPMS. The mutant cell 
lines cover a variety of DNA repair/tolerance pathways 
(e.g., BER, base excision repair; HEL, helicase; NER, 
nucleotide excision repair; NHEJ, non-homologous 
end-joining; TLS, translesion DNA synthesis; HR, 
homologous recombination; DDC, DNA damage 
checkpoint). Considering the weaker SN1-reactivity 
and stronger SN2-reactivity of MMS and EMS, we also 
exposed cells to these chemicals in order to see if the 
SN-1 dominant IPMS gave a different response from 
MMS and EMS. The LC50 in each mutant was compared 
to that in DT40 cells. The mean LC50’s in parental DT40 
cells were 736 µM, 65.7 µM, and 1234 µM for IPMS, 
MMS and EMS, respectively. For the mutant cell lines, 
the average of 3 or more independent experiments are 
plotted as the relative LC50 (Figure 1). Among these 
cell lines, DT40 cells deficient in FANC genes showed 
greater sensitivity to IPMS than to MMS or EMS. The 
relative LC50 of MMS or EMS in FANC-deficient cells 
was approximately 60%, while the value dropped to a 
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range of 10-40% in FANC-deficient cells treated with 
IPMS. On the other hand, IPMS showed moderate to no 
toxicity in the POLβ-, FEN1-, and PARP1-deficient DT40 
cells, while MMS or EMS showed obvious toxicity in 
these cells, suggesting that the BER pathways are less 
involved in the repair of IPMS-induced DNA damage. 
For the other mutant cells, there was no difference in the 
relative LC50 among all of the three sulfonic acids tested. 
Interestingly, the LC50 values in MMS- and EMS-treated 
mutants were comparable, suggesting that the DDR to 
these two chemicals are quite similar.
The involvement of the FANC pathway in the repair 
and tolerance of IPMS-induced DNA damage
In order to confirm that the hypersensitivity of DT40 
cells to IPMS results from a dysfunction in the FANC 
pathway, FANCD2-deficient cells were transfected with 
a functional FANCD2 plasmid and treated with IPMS, 
MMS or EMS. The sensitivity of these FANC2-deficient 
cells was compared with wild-type cells to determine if 
ectopic expression of FANC2 rescues its DNA damage 
repair function. After IPMS treatment, the survival curve 
of FANCD2-deficient cells transfected with the FANCD2 
plasmid is similar to that of wild-type cells and is 
significantly different from the survival curve of FANCD2 
mutant cells (Figure 2A). The obtained LC50 values 
were 75.99 µM, 253.4 µM and 355.1 µM in FANCD2, 
FANCD2+wt FANCD2 and wild-type cells, respectively. 
These results indicate that ectopic expression of FANCD2 
restored the resistance to IPMS. In contrast, no obvious 
difference was observed on the survival curves between 
FANCD2 and FANCD2+wt FANCD2 cells treated with 
MMS and EMS (Figure 2B and 2C). IPMS also caused 
hyper-sensitivity to cells expressing monoubiquitination-
deficient FANCD2 (FANCD2 K563R) (Figure 1). Thus, 
these results strengthen our findings that the FANCD2, 
or more specifically monoubiquitination of FANCD2 
at lysine 563, is critical for tolerating IPMS-induced 
DNA damage. We then addressed whether human cells 
deficient in FANCD2 are also hyper-sensitive to IPMS. 
To test this question, FANCD2 gene was deleted in human 
TK6 lymphoblastoid cells (Supplementary Figure S1). 
As with the DT40 cells, TK6 FANCD2 knock-out cells 
were markedly sensitive to IPMS in terms of cell toxicity 
(Figure 2D). Together, these results suggest that the FANC 
pathway plays a pivotal role in the repair or tolerance of 
IPMS-induced DNA damage.
Figure 1: DT40 cell-based DNA damage response assay for IPMS, MMS and EMS. Each mutant cell line lacking a specific 
gene was exposed to serial dilutions of each chemical, and the relative LC50 was normalized based on the LC50 in DT40 wild-type cells. The 
data shows the mean of at least three independent experiments. See Table 1  for the abbreviation of the DNA repair or tolerance pathways.
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The isopropyl moiety plays a crucial role in DNA 
damage response to IPMS in the absence of 
FANC repair machinery
To understand how the subtle change in chemical 
structure between IPMS and nPMS gives different 
cellular responses, we examined the sensitivity of FANC-
deficient cells to nPMS, which possesses the n-propyl 
moiety instead of the isopropyl moiety present in IPMS. 
The role of the FANC repair pathway in nPMS-derived 
DNA damage was investigated in comparison with IPMS-
derived DNA damage. The survival curve of FANCD2 
cells treated with IPMS is significantly different from 
that of wild-type cells while this difference was not 
observed when cells were treated with nPMS (Figure 3). 
The LC50 values were 1879 µM and 1421 µM in wild-
type and FANCD2 cells treated with nPMS, whereas 
the values were 706 µM and 142 µM in wild-type and 
FANCD2 cells treated with IPMS. No obvious difference 
in sensitivity to nPMS was observed in FANCG, FANCI, 
and FANCL compared to that in wild-type cells, suggesting 
that the FANC repair pathway is not the primary repair or 
tolerance pathway activated in response to nPMS-induced 
DNA damage.
No involvement of the MGMT repair pathway in 
IPMS-derived DNA damage in DT40 cells
To investigate the involvement of the MGMT 
repair pathway on IPMS- and nPMS-derived DNA 
damage and consequent cell death, DT40 wild-type cells 
pretreated with O6-benzyl guanine (OBG), which inhibits 
MGMT activity, were exposed to IPMS and nPMS. To 
see if inactivation of the MGMT repair pathway further 
potentiates the cytotoxicity of alkylating agents, the LC50 
values in the OBG pretreated group were compared with 
those in the untreated group. As a well-known alkylating 
agent, MMS was exposed in parallel. To determine if the 
FANC and MGMT repair pathways work independently, 
FANCI-, FANCG-, FANCL-, FANCC-, and FANCD2- 
deficient cells were also included in the assay. As a result, 
OBG pretreatment greatly reduced the LC50 values in all 
of the examined cells treated with nPMS and MMS, but 
not IPMS (Figure 4). These results are consistent with the 
fact that MGMT recognizes O6-methyl, ethyl, and propyl 
dG [25]. It is conceivable, therefore, that because O6-
isopropyl dG is poorly recognized by MGMT, MGMT 
depletion does not change the LC50, while O6-n-propyl 
dG or O6-methyl dG, which are recognized by MGMT, 
greatly reduce the LC50 in the pretreated cells. The same 
pattern was observed in the FANC-deficient mutants.
Greater MN induction in FANC-deficient cells 
treated with IPMS
The MN assay with IPMS was conducted in 
wild-type and FANC-deficient cells to determine the 
impact of a dysfunction in the FANC pathway on MN 
induction. Results revealed MN induction by IPMS 
treatment in both wild-type and FANC-deficient mutant 
cells (Figure 5A). The point of departure (PoD) analysis 
revealed that the break point concentration of MN 
induction over the baseline level was lower in FANCG-, 
FANCI- and FANCL-deficient cells compared to that of 
wild-type cells, with the calculated PoD being 81 µM, 
56 µM, and 51 µM in FANCG, FANCI and FANCL cells, 
respectively, as compared to 110 µM in DT40 wild-type 
cells. The PoD value indicates the concentration in which 
a biological effect is observed. Therefore, the lower PoD 
values observed in FANC-deficient cells indicate that the 
FANC pathway contributes to suppressing MN formation 
upon IPMS treatment. We also investigated the impact of 
MGMT inhibition on MN induction by IPMS or nPMS to 
examine whether the differential recognition between O6-
isopropyl dG and O6-n-propyl dG by MGMT influences 
the MN results, as observed in the cytotoxicity assay. Cells 
Table 1: A list of examined DT40 mutant cell lines
DNA repair/tolerance pathway Genes
Base Excision Repair (BER) POLβ, FEN1, PARP1
RecQ like Helicase BLM, WRN
Nucleotide Excision Repair (NER) XPA, XPG
Non-Homologous End-Joining (NHEJ) LIGIV, KU70
Homologous Recombination (HR) RAD54, BRCA1, BRCA2, FANCI, FANCG, FANCC, FANCL, 
FANCD2, FANCD2-K563R (monoubiquitination-deficient mutant), 
CTIP
DNA damage checkpoint (DDC) RAD9, ATM




pretreated with OBG were exposed to IPMS or nPMS, 
and the MN frequency was measured. As a result of two 
independent experiments, both chemicals increased the MN 
frequency in both wild-type and FANCD2-deficient cells 
(Figure 5B). The spontaneous MN frequency was higher 
in FANCD2 cells (0.4%) than in wild-type cells (0.1%), 
suggesting that the FANC pathway plays a protective role 
against spontaneously occurring DNA damage. The OBG 
pretreatment increased the MN frequency in wild-type cells 
treated with nPMS, but it did not increase the frequency 
in wild-type nor FANCD2-deficient cells treated with 
IPMS. The OBG pretreatment also reduced the relative 
population doubling in wild-type cells treated with nPMS, 
but not for IPMS-treated cells. In the FANCD2 cells treated 
with nPMS, OBG pretreatment slightly increased the MN 
frequency, but the effect was not significant. These results 
indicate that, in contrast to O6-isopropyl dG, MTMT 
removal of O6-n-propyl dG reduces MN formation.
Induction of DSBs in DT40 and TK6 cells treated 
with IPMS
Next, we addressed whether O6-isopropyl dG 
generates DSBs and if the inability to repair DSBs in 
FANC-deficient cells results in an accumulation of DSBs, a 
higher incidence of cell death, and MN induction by IPMS. 
To do this, we analyzed the population of γH2AX-positive 
cells in wild-type and FANCD2-deficient cells. After a 
4-hour treatment with IPMS, the population of γH2AX-
positive cells in both wild-type and FANCD2-deficient cells 
showed a linear dose response at a concentration of 100 
µM or higher (Figure 6A). In cells that were not treated 
with IPMS, 4.2 and 11.6% of wild-type and FANCD2-
deficient cells were positive for γH2AX, respectively. 
The evidence for FANC involvement in DSB repair [27] 
is consistent with our observation that FANCD2-deficient 
cells display a higher incidence of γH2AX. To estimate 
Figure 2: FANCD2 plays a critical role on cell survival in the presence of IPMS. FANCD2-deficient cells transfected with the 
FANCD2 plasmid were exposed to IPMS A. MMS B. or EMS C. at 8 concentrations in parallel with FANCD2 knock-out and wild-type 
cells. D. FANCD2 knock-out (two clones) and wild-type TK6 cells were treated with IPMS. After treatment, cell viability was evaluated 
with XTT, and the relative survival at each concentration was calculated. The data shows the mean and standard deviation of at least three 
independent experiments.
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the number of IPMS-induced γH2AX-positive cells, these 
baseline values were subtracted from the observed values 
at each time and dose point. Time course experiments 
revealed that there was an increase in γH2AX-positive cells 
within 1 hour of treatment in both wild-type and FANCD2-
deficient cells treated with 400 µM IPMS. The number of 
γH2AX-positive cells peaked at 4 hours after treatment, 
and this peak was maintained thereafter. In FANCD2-
deficient cells, the percentage of γH2AX-positive cells is 
almost twice that of wild-type cells at the 4- and 6-hour 
treatment time points (Figure 6B). We also examined 
nuclear γ-H2AX and 53BP1 foci formation in TK6 cells 
after 24-hour exposure to IPMS. A marked increase in 
both γ-H2AX and 53BP1 foci formation was observed in 
IPMS-exposed cells compared to control (Figure 7). To test 
if both γ-H2AX and 53BP1 are co-localized as foci, we 
performed co-immunostaining of TK6 cells with γ-H2AX 
and 53BP1. Many γ-H2AX foci were co-localized with 
53BP1 foci, indicating that IPMS causes DSBs in human 
TK6 cells as well.
Figure 3: Differential toxicity of IPMS and nPMS in FANCD2-deficient DT40 cells. The cytotoxicity of IPMS and nPMS in 
FANCD2-deficient cells was examined. FANCD2-deficient cells and wild-type cells were exposed to IPMS and nPMS at 8 concentrations. 
After treatment, cell viability was evaluated with XTT, and the relative survival at each concentration was calculated. The data shows the 
mean and standard deviation of at least three independent experiments.
Figure 4: Impact of MGMT function on the toxicity of IPMS, nPMS, and MMS in DT40 cells deficient and proficient 
in FANC genes. Wild-type and FANC-deficient cells with or without O6-benzylguanine pre-treatment were exposed to IPMS, nPMS or 
MMS. After treatment, XTT was added, and cell viability was measured. Based on the cell viability data, the LC50 was calculated in each 
treatment condition. The LC50 with pre-treatment is divided by the LC50 without pre-treatment and expressed as percentage. The data shows 
the mean and standard deviation of at least three independent experiments.
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DISCUSSION
The present study was conducted to elucidate the 
repair or tolerance pathway activated in response to IPMS 
and to understand how O6-isopropyl dG leads to cell death 
and/or genomic damage. To characterize cellular response 
to IPMS treatment, we compared the genotoxicity and 
cytotoxity potential between IPMS and nPMS, which 
is an isomer of IPMS that lacks the isopropyl moiety 
and exhibits weaker SN-1 reactivity and stronger SN-2 
Figure 5: Micronucleus induction in wild-type and FANC-deficient cells treated with IPMS. A. The fold increase in MN 
frequency over the control in DT40 wild-type, FANCI, FANCG and FANCL mutants treated with IPMS for 16 hours is shown. The relative 
population doublings are also plotted. The data shows the mean and standard deviation of two independent experiments. B. This experiment 
was conducted to examine the effect of MGMT inhibition on micronucleus induction in wild-type and FANCD2-deficient cells treated with 
IPMS or nPMS. Wild-type or FANCD2-deficient cells with or without O6-benzylguanine pre-treatment were exposed to IPMS or nPMS. 
After 16 hours of treatment, cells were harvested and stained with fluorescence dye for the flow cytometry-based MN assay. Statistical 
analyses were conducted for the MN frequency comparing the pre-treated samples against the samples without pretreatment. The relative 
population doublings are also plotted. The data shows the mean and standard deviation of two independent experiments.
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reactivity. Due to the higher SN1-reactivity of IPMS, we 
hypothesized a greater percentage of O6 adducts from 
IPMS treatment. Comparison of the sensitivity of wild-type 
and FANCD2-deficient cells to IPMS and nPMS revealed 
that the branched alkyl moiety of IPMS is a key structure 
that mediates the hypersensitivity of FANC-deficient cells 
to IPMS, and that the cellular response to nPMS is similar 
to that of MMS and EMS. Alkyl groups in O6-alkyl dG 
adducts are repaired by MGMT; however, the repair 
efficiency of this enzyme varies depending on the substrate. 
It has previously been seen that O6-isopropyl dG is less 
extensively repaired than O6-methyl dG or O6-ethyl dG 
[28], but it remained unclear how this difference in repair 
efficiency affects cellular responses (e.g. measured as 
cytotoxicity, mutagenicity and clastogenicity). To examine 
the impact of differences in efficiencies of the MGMT repair 
pathway on cell survival, wild-type and FANC-deficient 
cells were exposed to IPMS, nPMS or MMS with and 
without pretreatment with O6-benzyl guanine (OBG), an 
inhibitor of MGMT. Pretreatment with OBG did not change 
the LC50 values of IPMS in wild-type or FANC-deficient 
cells, while OBG potentiated the cytotoxicity of nPMS and 
MMS in all of the cells examined. These results suggest that 
MGMT is not involved in the repair of O6-isopropyl dG and 
does not rescue cells from death, but instead repairs O6-n-
propyl dG and O6-methyl dG and promotes cell survival. 
These findings are consistent with the report that O6-n-
propyl dG is recognized by MGMT as efficiently as O6-
methyl guanine and O6-ethyl dG [25]. Taken together, the 
sensitivity of FANC-deficient cells to IPMS, nPMS, MMS 
and EMS is associated with MGMT recognition activity of 
the adduct type that is generated.
Figure 6: IPMS-induced γH2AX in DT40 cells with or without functional FANCD2. A. Dose response of γH2AX was 
examined in wild-type and FANCD2-deficient cells treated with IPMS. Cells were treated with IPMS for 4 hours, and the γH2AX expression 
was measured. The y-coordinate indicates the population of γH2AX-positive cells. Each measurement represents the mean and standard 
deviation of two independent experiments. B. Expression of γH2AX was examined in a time-dependent manner in wild-type and FANCD2-
deficient cells treated with IPMS. The kinetics of γH2AX induction was investigated after treatment with 400 μM IPMS in wild-type and 
FANCD2-deficient cells. Cells were exposed to IPMS at different times at 39°C, and cells were harvested thereafter for immunostaining and 
flow cytometry-based analyses. Each measurement represents the mean of two independent experiments.
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Consistent with the observation that O6-isopropyl 
dG escapes recognition and repair by MGMT, IPMS-
treated cells accumulated more DNA damage than nPMS-, 
MMS- or EMS-treated cells and thus demonstrate higher 
cytotoxicity. These unrepaired DNA lesions are assumed 
to lead to MN formation. Our PoD analysis in wild-type 
and FANC-deficient cells revealed that the FANC pathway 
suppresses IPMS-induced MN formation. In the DDR 
assay using DT40 mutant cells, BRCA2, FANCD2, FANCI, 
FANCG, FANCL, REV1, REV3, RAD9, RAD18 and PCNA 
K164R mutants were hypersensitive to IPMS. Among these 
cells, the FANC pathway mutants were exclusively sensitive 
to IPMS while REV1, REV3, and PCNA K164R mutants 
were comparably sensitive to IPMS, MMS or EMS. These 
results suggest that the FANC repair pathway plays a pivotal 
role in repairing or tolerating IPMS-induced DNA damage 
compared to the other genes universally involved in repair or 
tolerance of alkylated DNA damages. Exogenous expression 
of the FANCD2 gene in FANCD2-deficient cells restored the 
resistance to IPMS. The FANC pathway is known to function 
in DNA cross-link repair, homologous recombination and 
resolution of the replication arrest [29, 30]. If O6-methyl dG 
is left unrepaired, DNA replication over the O6MeG results 
in an O6MeG:T mismatch or O6MeG:C ambiguous pair 
[31]. Subsequently, the mismatch repair pathway works to 
fix the mismatch. However, since O6MeG remains in the 
template, a futile repair loop can eventually result in highly 
toxic DSBs during DNA replication [32, 33]. The same 
cellular response likely takes place in IPMS-treated cells. 
IPMS may generate mismatch repair pathway-mediated and 
replication-associated DSBs, which appear to be repaired 
by the FANC pathway. Monoubiquitylation of FANCD2 
and FANCI is critical for downstream FANC pathway 
activation in the repair and tolerance of crosslinking DNA 
damage [34]. Monoubiquitination of FANCD2 and FANCI 
is catalyzed by the FANC core complex, including FANCG 
and FANCC, through the ubiquitin ligase subunit FANCL 
[35]. Our results show that DT40 cells deficient in FANCD2, 
Figure 7: Induction of 53BP1 and γH2AX foci in TK6 cells following exposure to IPMS. TK6 cells were exposed to IPMS 
(750 µM) for 24h and co-immunostained with anti-53BP1 (green) and anti- γH2AX (red). Nuclei were counterstained with DAPI (blue). 
The images were captured using confocal microscopy and represents maximum intensity projections of z-stacks. Magnification, 600X.
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FANCI, FANCG, or FANCL are hyper-sensitive to IPMS 
as compared to MMS and EMS, and monoubiquitination-
deficient FANCD2 mutant cells are also markedly sensitive to 
IPMS. This suggests that mismatch repair pathway-coupled 
O6-alkylguanine-mediated DSBs during DNA replication 
activates the Fanconi anemia core complex and leads to 
the monoubiquitination of FANCD2 and FANCI. DT40 
mutants deficient in BRCA2 were also hyper-sensitive to 
IPMS, indicating that the monoubiquitination of FANCD2 
and FANCI further stimulates downstream components of 
the FANC pathway to repair and tolerate DSBs caused by 
O6-alkylguanine. Interestingly, both RAD18 and RAD9-
deficient DT40 cells showed a similar trend of toxicity with 
lesser extent than FANC-deficient cells, suggesting that these 
DDR pathways could involve the upstream events of FANC 
pathway. Indeed, the FANC pathway is activated by RAD18, 
which also interacts with ubiquitinated chromatin components 
and facilitates RAD9 recruitment to DNA DSBs [35, 36].
As unrepaired DSBs result in the formation of MN 
after cell division, we examined MN induction in cells 
treated with IPMS and nPMS in the presence and absence 
of OBG. The MN assay revealed that MGMT dysfunction 
elevated the MN induction frequency in wild-type cells 
treated with nPMS but not IPMS. MGMT did not affect 
MN frequency in FANCD2-deficient cells. These results 
indicate that O6-n-propyl dG accumulates in the absence of 
MGMT activity, but loss of MGMT activity does not change 
the number of O6-isopropyl dG adducts that remains on 
the DNA and eventually form MN or kill cells. An increase 
in MN frequency was not observed in OBG-pretreated 
FANCD2 cells after treatment with nPMS. High spontaneous 
MN frequency in FANCD2 cells, which is consistent with 
a previous report [37], may make it challenging to detect 
the small increases in MN frequency by MGMT inhibition. 
The increase in time-dependent accumulation of DSBs in 
FANCD2-deficient cells compared to wild-type cells may 
explain the stronger cytotoxicity and higher incidence of 
MN formation in FANC-deficient cells treated with IPMS. 
It is worthwhile to note that spontaneous MN frequency in 
FANCG-, FANCI-, and FANCL-deficient DT40 cells were 
1.8, 3.4, and 6.6 times higher, respectively, than that in wild-
type DT40 cells. Due to markedly high spontaneous MN 
frequency, the relative increase in MN frequency in FANCL-
deficient DT40 cells is comparable to that in wild-type DT40 
cells (Figure 5A). In contrast, the PoD concentration, which 
is indicative of a biologically significant increase, differed 
between wild type cells and FANCL-deficient cells. FANCL-
deficient cells showed a lower value than that in wild type 
cells, which suggest FANCL-deficient cells are more sensitive 
to MN induction by IPMS.
The observation that the isopropyl moiety is a key 
structure that escapes recognition by MGMT can potentially 
be applied to cancer chemotherapy, since recent clinical 
trials have been undertaken to test DNA repair inhibitors 
that target PARP, BER, or MGMT in combination with 
alkylating agents [38]. In the case of OBG, a phase I clinical 
trial has defined the maximum tolerated dose of a single dose 
of TMZ when combined with OBG and has determined the 
dose of OBG that depletes tumor MGMT activity for 48 h 
[39]. Since IPMS causes MGMT-resistant O6-isopropyl dG 
and potential BER substrates such as N7-isopropyl dG and 
N3-isopropyl dA, co-treatment of IPMS and PARP inhibitor 
could cause synthetic lethality in HR-deficient tumor cells 
due to accumulation of DSBs caused by O6-isopropyl dG 
and induced by PARP1-DNA strand break complex during 
DNA replication. Therefore, incorporation of the isopropyl 
moiety may be worthwhile to test in future clinical trials, 
or test as a cancer chemotherapeutic approach, although 
the success of such approaches will of course depend on 
selective targeting of the tumor.
Overall, our findings in the present study reveal that 
IPMS-induced DNA damage escapes recognition by MGMT 
and generates DSBs. This leads to an activation of cell cycle 
checkpoints and results in FANC-mediated DSB repair.
MATERIALS AND METHODS
Chemicals
Isopropyl methanesulfonate (IPMS), ethyl 
methanesulfonate (EMS), methyl methanesulfonate 
(MMS), 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino) carbonyl]-2H-tetrazolium hydroxide 
(XTT), 1-methoxy-5-methylphenazinium methyl sulfate 
(PMS), O6-benzylguanine and dimethylsulfoxide (DMSO) 
were obtained from Sigma. Propyl methanesulfonate 
(nPMS) was purchased from Tokyo Chemical Industry 
Co., Ltd. (Tokyo, Japan). Dulbecco’s phosphate buffered 
saline (PBS) was obtained from Life Technologies (Grand 
Island, NY, USA). All of the chemicals were dissolved in 
PBS, except XTT which was dissolved in DMSO.
DT40 cell culturing and maintenance
Fetal bovine serum (FBS) and penicillin/
streptomycin were obtained from Atlanta Biologicals 
(Norcross, GA, USA) and Sigma-Aldrich (St. Louis, 
MO, USA), respectively. RPMI 1640 culture medium 
(+glutamine, –phenol red) and chicken serum (CS) 
were acquired from Life Technologies (Grand Island, 
NY, USA). FBS and CS were heat inactivated at 56°C 
for 30 min. DT40 cells were maintained as described 
in our previous report [13]. The DT40 cell line and its 
isogenic mutants were knocked out in specific DNA repair 
pathways (Supplementary Table S1).
Generation of FANCD2 knockout TK6 cell lines 
and cell cultivation
To disrupt the FANCD2 gene, the guide RNA 
sequence (5’- TTTGGAAAGTGGTTGCTTCC -3’) 
was designed against exon 2 and cloned into the pX330 
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(Addgene) plasmid after digestion with BbsI. To generate 
the targeting vectors, the left and right arms were amplified 
by polymerase chain reaction (PCR) using 5’-GCGAATTG
GGTACCGGGCCCATTGAGTCTCAAATTTGGT-3’/5’-
CTGGGCTCGAGGGGGGGCCAATATGGCAAATAGTA
AAGG -3’ (for the left arm), and 5’-TGGGAAGCTTGTC
GACTTAACAGAATCAACTAGGTAATAT-3’/5’-ACTAG
TAGGCGCGCCTTAAGCTTCTTTTGGAAAGCTATT-3’ 
(for the right arm), respectively. The amplified fragments of 
the left and right arms were assembled by Seamless Cloning 
(A14606, Invitrogen) into the DT-ApA/NEOR (provided 
from the Laboratory for Animal Resources and Genetic 
Engineering, Center for Developmental Biology, RIKEN 
Kobe, http://www.cdb.riken.jp/arg/cassette.html) and DT-
ApA/PUROR cassettes [40] which were digested with ApaI 
and AflII. The single underlines seen above indicate the 
homology of upstream and downstream from ApaI site. The 
double underlines above indicate the homology upstream 
and downstream from AflII site. The gene disruption was 
confirmed via immunoblot using an anti-FANCD2 antibody 
(sc-2022, Santa Cruz). β-actin (A5316, Sigma) was used as 
a loading control. TK6 cells were maintained in RPMI 1640 
culture medium (+glutamine, –phenol red) supplemented 
with FBS (10%) and penicillin/streptomycin.
DT40 cell-based DNA damage response (DDR) 
assay
For the DDR assay, approximately 1,200 cells were 
seeded in each well of a 96-well plate in 75 μL of medium. 
The wild-type and mutant cells were seeded in one plate, 
and the cells were treated with IPMS, MMS or EMS in 
duplicate wells for each chemical. The outside 2 wells 
were used as blank controls. These plates were kept in an 
incubator at 39.5°C until the start of treatment. Separately, 
each chemical was serially diluted into eight concentrations. 
8.35 µL of the chemical solutions or PBS (as a solvent 
control, 2 wells/row) were added to 2 rows of a 96-well 
plate. A preliminary dose finding test was conducted in 
DT40 wild type cells to select the appropriate concentration 
range, which included at least one concentration showing 
severe cytotoxicity and one concentration showing no 
cytotoxicity at a lower concentration.
After the chemical solutions were added, plates 
were incubated for at least 48 hours after which they were 
intermittently observed microscopically to determine the 
growth of the cells. Once the control cells covered 1/3 or 
more of a well bottom, cells were exposed to the XTT 
cocktail. The plates were returned to the incubator until 
the dye developed sufficient color for detecting absorbance 
on the plate reader, which normally takes 2-5 hours. 
Absorbance was measured at 450 nm with a reference of 
620 nm using a Tecan Sunrise (Tecan Systems, San Jose, 
CA, USA) plate reader with XFluorTM software (Tecan, 
version 6.4). All data are summarized as the means of 
experiments done at least in triplicate.
Micronucleus assay
For the micronucleus assay, flow cytometry-based 
MN measurements were performed using an In Vitro 
MicroFlow™ Kit (Litron Laboratories, Rochester, NY, 
USA) according to the manufacturer’s instructions [41]. 
Briefly, 150 µL of DT40 cells adjusted to 2 × 105 cells/ml 
were seeded into 96-well plates at 39°C and 5% CO2 in 
a humid atmosphere. Chemical solutions were separately 
prepared, and 16.7 µL of the solutions were added to each 
well. Cells were cultured at 39°C for 16 hours, which 
corresponds to approximately two cell cycles. After 
treatment, the plate was centrifuged to collect cells, and 
the treatment medium was discarded. The plate was then 
placed on ice and incubated for 20 min, and 50 μL of 
Nucleic Acid DyeA working solution was added to each 
well. A light source was placed approximately 15 cm 
above the samples for 30 min. Subsequently, the samples 
were washed once with cold 1x Buffer Solution. Next, 100 
μL of Complete Lysis Solution 1 (including Nucleic Acid 
DyeB) were added to each well, and the samples were 
incubated for 1 hour in the dark at 37°C. Subsequently, 
100 μL of Complete Lysis Solution 2 (including Nucleic 
Acid DyeB) were added to each well, and the samples 
were incubated for 30 min in the dark at room temperature.
Samples for the MN assay were analyzed by flow 
cytometry (FACS Calibur or LSRII, BD Biosciences) 
using an excitation wavelength of 488 nm. The frequency 
of MN was determined by acquiring at least 10,000 gated 
nuclei per sample. The data is summarized as a mean 
of two or more independent experiments. The extent 
of survival in the treated cultures was evaluated as the 
reduction in population doubling (PD). This is described 
as relative population doubling (RPD), which is calculated 
using the following formula:
(Number of PD in treated cultures)/(Number of PD 
in control cultures) × 100,
where PD is calculated as
[log(post-treatment cell number/initial cell 
number)]/log 2.
Pretreatment with O6-benzylguanine
Cells were pretreated with O6-benzylguanine (OBG) 
and used for both the DDR and MN assays to see if 
MGMT inhibition changes the cellular response. Prior to 
treatment, cells were pre-incubated with 10 µM of OBG 
for 2 hours and exposed to chemicals. No additional OBG 
was supplemented during the exposure.
γH2AX assay
To determine the percentage of γH2AX-positive 
cells, IPMS-treated cells were harvested and stained 
with a FITC conjugated γH2AX antibody using an 
H2A.X phosphorylation Assay Kit for Flow Cytometry 
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(Millipore Corporation, CA, USA) according to the 
manufacturer’s instructions. Briefly, 1 × 106 cells were 
exposed to chemicals and harvested after a 1, 2, 4, 8 
or 16 hour treatment period. Cells were washed once 
with PBS and resuspended in 200 µL of 1X Fixation 
solution and stored on ice for 20 minutes. After fixation, 
cells were washed with PBS and resuspended in 100 
µL of 1X Permeabilization solution, in which 3.5 µL 
of anti-phospho-Histone H2A.X (Ser139) was added. 
After incubation on ice for 20 minutes, 100 µL of 1X 
Wash solution was added. The cells were harvested by 
centrifugation and resuspended in 200 µL of PBS. The 
samples were analyzed by flow cytometry (FACS Calibur, 
BD Biosciences), and the data was analyzed by FlowJo 
(Ver. X, Tree Star, Inc.).
Immunofluorescence
TK6 cells (0.5 million/ml) were exposed to IPMS 
(750µM) for 24 hours. Cells were then fixed using 2% 
formaldehyde / PBS for 20 min, washed in PBS, and 
spotted on to double frosted microscopic glass slides 
(Fisher Scientific) at a concentration of 2 million/ml. 
Blocking was achieved using 5% (w/v) bovine serum 
albumin (BSA) in PBS-TT for 30 min. Cells were then 
incubated with 1:500 rabbit polyclonal anti-53BP1 
antibody (Bethyl Laboratories, Montgomery, TX) and 
mouse γH2AX antibody (Millipore Corporation, CA, 
USA) in 1% BSA/PBS-TT for overnight at 4oC. Cells 
were then washed in PBS, incubated in 1:250 anti-mouse 
Alexa Fluor 555 (Life Technologies) and Alexa Fluor 488 
antibodies (Jackson ImmunoResearch Laboratories, West 
Grove, PA) for 1h. After washing with PBS, slides were 
mounted with a cover slip using Vectashield with DAPI 
(Vector Laboratories) and sealed using nail polish. Slides 
were analyzed using confocal microscopy (Zeiss CLSM 
700). Optical sections through the nuclei were captured 
at 0.5 µm intervals, and the images were obtained by 
maximum projection of the individual sections.
Data and statistical analysis
For DDR assay data sets, we calculated the lethal 
concentration 50 (LC50) values for each cell line using 
Graphpad Prism 5 (La Jolla, CA, USA). The obtained LC50 
in each mutant was compared against the LC50 in wild-
type cells.
In order to represent the point of departure values 
for concentration-response in the MN assay in wild-type 
and FANC-deficient cells, the benchmark dose (BMD) 
values (U.S.EPA/100/R-12/001 2012) were obtained using 
the EPA BMD software v 2.5. These values represent a 
one standard deviation departure from control values, and 
the BMDL refers to the corresponding lower limit of a 
one-sided 95% confidence interval on the BMD. A log10 
(concentration+0.5) was used to avoid taking logarithms 
of zero control values. In each instance, the best fitting 
result from Hill, exponential, and polynominal response 
non-constant variance models was used.
Fisher’s exact test was used to examine whether 
the micronucleus frequency differed between the OBG 
pretreated cells and untreated cells following IPMS 
or nPMS treatment. The results were determined to 
be statistically significant when the P-value was less 
than 0.05.
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